■ Market Review

On Oct. 24, Ilyang Pharmaceutical (007570) declined 2.71% to 41,350 won (US$ 36.49). It had declined 16.21% through the past month. Standard deviation, which indicates volatility of stock, records 2.5% over the same period over one month.

Compared with its close competitors within the same industry, KOSPI, even though the monthly earnings rate of Ilyang Pharmaceutical recorded negative, its volatility for 1 month was proper. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.4%. In spite of stock price decline, the return-on-risk remained around the average of its peer group. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, -0.5, and thus it is hard to say that the industrial comparison performance was positive.

Close Competitors Earning rate (%) STD (1Mo) Return on Risk (1Mo)
1 Mo 3 Mo 6 Mo
HANALL BIOPHARMA(009420) -30.0% -39.9% -12.4% 3.2% -9.3
DAEWOONG PHARMA(069620) -7.3% -25.7% -21.8% 2.6% -2.8
ILYANG PHARM(007570) -16.2% -20.5% -16.1% 2.5% -6.4
DONG-A ST(170900) -17.4% -24.0% -36.1% 2.2% -7.9
BORYUNG PHARM(003850) -7.8% -6.8% 6.4% 1.8% -4.3
Medical Supplies -17.0% -16.8% -21.7% 1.7% -10.0
KOSPI -0.3% -0.6% 1.3% 0.6% -0.5

■ Earnings & Valuation

ILYANG PHARM(007570): 2Q(Apr ~ June) of 2016 Earnings (reported at July 26. 2016)
Revenue Operating Income Net Income
2Q of 2016 616.0 T 42.1 T 27.0 T
Previous Quarter 5.5% increase 42.7% decline 34.2% decline
YoY 43.8% increase 142.1% increase 233.8% increase

Financial structure Overview

Compared with 4 close competitors with similar market capitalization within its industry, ILYANG PHARM's P/B ratio, a financial ratio of a company's book value, and its P/E ratio, a price-paid ratio of annual net income, are both at a relatively higher level.

P/E ratio and P/B ratio

Close Compatitors ROE PER PBR Basic Date
ILYANG PHARM(007570) 5.4 69.7 3.8 June 2016
DAEWOONG PHARMA(069620) 3.5 42.3 1.5 June 2016
HANALL BIOPHARMA(009420) -4.1 - 7.1 June 2016
DONG-A ST(170900) 5.0 28.7 1.4 June 2016
BORYUNG PHARM(003850) 10.4 24.3 2.5 June 2016

■ Investor Group

Institutions and Foreigners sell, Individuals buy While institutions have been selling Ilyang Pharmaceutical during the past 7 trading days, foreigners have been buying during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have sold 74,034 shares and institutions have sold 72,817 shares with a selling trend. However, during the same period, individuals have bought 146,851 shares with an increasing position.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

* Other Investor groups, included as "other corporations", are considered as "Individuals".

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.